loader
Please Wait
Applying Filters...

Evonik Evonik

X

Approved Marketing Authorisations (MA) containing Buserelin Acetate in Europe. Original Data : EMA Website

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 SANOFI SpA (4)

02 Sanofi AB (4)

03 Sanofi-aventis Norway (3) (1)

04 Abacus Medicine A / S (2)

05 Medartuum AB (1)

06 Orifarm AB (2)

07 Orifarm AS (1)

08 Paranova Pharmaceutical AB (2)

09 Pharmachim AB (1)

filter

01 Buserelin (6)

02 buserelin acetate (12)

filter

01 Buserelin 0.1Mg/Spray Dispensing Nasal Use (1)

02 Buserelin 1Mg/Ml 5,5Ml 1 Unit Parenteral Use (1)

03 Buserelin 6,3Mg 1 Unit Parenteral Use Rp (1)

04 Buserelin 9,45Mg 1 Unit Parenteral Use Rp (1)

05 IMPLANT (9)

06 NASAL SPRAY, SOLUTION (2)

07 Nose spray, resolution (2)

08 SOLUTION FOR INJECTION (1)

filter

01 Italy (4)

02 Norway (2)

03 Sweden (12)

filter

01 Suprecur (4)

02 Suprefact (4)

03 Suprefact Depot (9)

04 Suprefact Nasal (1)

URL Supplier Web Content
NASAL SPRAY, SOLUTION
0.15 MG / DOSE
Suprecur
Sweden
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
SOLUTION FOR INJECTION
1 MG / ML
Suprefact
Sweden
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
IMPLANT
9.45 MG
Suprefact Depot
Sweden
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
IMPLANT
6.3 MG
Suprefact Depot
Sweden
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
Buserelin 0.1Mg/Spray Dispensing Nasal Use
nasal soluz 0.1 mg/erog 1 bottle 10 mg
Suprefact Nasal
Italy
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
Buserelin 1Mg/Ml 5,5Ml 1 Unit Parenteral Use
1 ampoule SC 5.5 ml 1 mg/ml
Suprefact
Italy
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
Buserelin 6,3Mg 1 Unit Parenteral Use Rp
1 syringe SC 6.3 mg prolonged release
Suprefact
Italy
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
Buserelin 9,45Mg 1 Unit Parenteral Use Rp
1 syringe SC 9.45 mg plant depot
Suprefact
Italy
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
Nose spray, resolution
0.15 mg/dose
Suprecur
Bottle of dark glass with dose pump
Norway
Sanofi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier

Pharmachim AB

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
NASAL SPRAY, SOLUTION
0.15 MG / DOSE
Suprecur
Sweden
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY